|Chemical name: Insulin Glargine
Typical dosage: 300 units/ml
Typical type: Injection1
Toujeo® is a medication used to control blood sugar in type 1 and type 2 diabetes. Toujeo is only available as brand name and is available as a subcutaneous injection solution.
Toujeo is a prescription medication that contains the active ingredient insulin glargine, which is a long acting insulin.
Toujeo is provided as a pen injection device and can be injected on top of the thigh, the belly area or upper arm. This medication is injected once or multiple times daily, depending on your insulin regimen.
The major side effects of Toujeo include irritation where the shot is given, back pain, diarrhea, headache, weight gain and nose or throat irritation.
Yes! 72% of Medicare Advantage plans and Medicare Part D plans cover Toujeo.1
Drug coverage may vary based on plan availability. You may be able to find Medicare Advantage plan options in your area that cover Toujeo.
Find Medicare Advantage plans with drug coverageCompare Plans
Or call TTY Users: 711 24/7 to speak with a licensed insurance agent.
You can also compare Part D prescription drug plans available where you live and enroll in a Medicare prescription drug plan online when you visit MyRxPlans.com.
Your copay and deductible costs for any prescription drug can vary depending on what coverage stage you’re in.
|Deductible stage||Typical copay stage|
|Your deductible is the amount of money you must spend on covered drugs before your Medicare drug coverage starts paying its share of costs.
In the deductible stage, you’re responsible for the full cost of your prescription drugs.
Some Medicare prescription drug plans have a $0 deductible. Medicare drug plans cannot have a deductible more than $415 in 2019.
|After you meet your Part D deductible, you enter the initial coverage period.
During this phase (the typical copay stage), you pay a copayment (flat fee) or coinsurance (percentage) for your covered medications.
|$42 – $447||$25 – $447|
Your Toujeo dose may be adjusted continuously to achieve glucose control and to avoid low blood sugar.
Low blood sugar can happen while taking Toujeo. Signs of low blood sugar include dizziness, headache, sleepiness, weakness, hunger, shaking, confusion and sweating. Talk to your doctor if you experience these symptoms.
Toujeo should be avoided in patients with diabetic ketoacidosis and used with caution for patients with liver and kidney impairment.
Your pen injection device should never be used for more than 1 person – even after the needle is changed – because of the risk of infection. The injection device should be clearly labeled with individual patient information to ensure that the correct pen is used.
Call your doctor if you experience signs of low potassium (e.g., weakness, muscle pain, muscle cramps, unusual heartbeat), signs of infection, dizziness or passing out, seizures, shortness of breath, weight gain, swelling of the arms and legs or change in mood.
This article is for informational purposes only. It is not healthcare advice, treatment, or diagnosis. It is not an endorsement of or recommendation for this medication. Speak to your doctor or healthcare provider about your specific healthcare needs, including your prescription medications. Only take medication as directed by your doctor.
Coverage and costs of prescription medications will vary by Medicare plan. Not all plans are available in all areas.
Written by Hayden Gharibyar, Pharm.D.